Want to see AU:AHC full AI Analyst Report?
AHC Stock Chart & Stats
AU$0.22
>-AU$0.01(-2.22%)
At close: 4:00 PM EDT
AU$0.22
>-AU$0.01(-2.22%)
Day’s Range― - ―
52-Week RangeAU$0.19 - AU$0.45
Previous CloseN/A
Volume362.21K
Average Volume (3M)274.87K
Market Cap
AU$93.69M
Enterprise ValueAU$82.74
Total Cash (Recent Filing)AU$16.28M
Total Debt (Recent Filing)AU$3.95M
Price to Earnings (P/E)10.3
Beta0.74
Next Earnings
Feb 25, 2027EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend Yield3.96%
Share Statistics
EPS (TTM)0.02
Shares Outstanding374,751,280
10 Day Avg. Volume383,620
30 Day Avg. Volume274,870
Financial Highlights & Ratios
PEG Ratio0.21
Price to Book (P/B)1.50
Price to Sales (P/S)0.99
P/FCF Ratio7.95
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
AU$0.45Price Target Upside104.55% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2
EPS Forecast (FY)0.02
Revenue Forecast (FY)AU$101.15M
Bulls Say, Bears Say
Bulls Say
Accelerating Revenue And Earnings GrowthThe sharp 2026 revenue acceleration, combined with higher net income and an improved net margin, indicates strong recent commercial expansion and product adoption. If sustained, this scale can strengthen AHC’s market position and provide greater operating capacity for continued investment.
Conservative Balance SheetVery low leverage gives AHC financial flexibility and reduces exposure to interest costs or refinancing pressure. A growing equity base and healthy ROE also show that the company is generating reasonable returns from shareholder capital, supporting resilience through the next several quarters.
Integrated Healthcare Workflow OfferingProducts embedded in clinical communication and hospital workflow processes can become operationally important once installed. Integration with IT and telephony infrastructure, together with lifecycle support, may reinforce customer relevance and create durable relationships beyond an initial system sale.
Bears Say
Gross Margin CompressionA material gross-margin decline means rapid sales growth is converting less efficiently into gross profit. The stated possibility of less favorable mix or higher input and fulfillment costs creates a durable risk that future revenue expansion may deliver weaker incremental profitability unless margins recover.
Inconsistent Cash ConversionAlthough cash generation is positive in recent years, the sharp 2026 free-cash-flow decline and moderate operating-cash-flow coverage show that accounting earnings are not converting consistently into cash. This can constrain internally funded growth and make execution more dependent on working-capital performance.
Limited Operating Margin ExpansionStable operating margins are less encouraging when viewed alongside very strong revenue growth, because the business is not yet demonstrating clear operating leverage. Without meaningful expansion, additional scale may provide less improvement in underlying earnings power than top-line growth suggests.
AHC FAQ
What was Austco Healthcare Limited’s price range in the past 12 months?
Austco Healthcare Limited lowest share price was AU$0.19 and its highest was AU$0.45 in the past 12 months.
What is Austco Healthcare Limited’s market cap?
Austco Healthcare Limited’s market cap is AU$93.69M.
When is Austco Healthcare Limited’s upcoming earnings report date?
Austco Healthcare Limited’s upcoming earnings report date is Feb 25, 2027 which is in 156 days.
How were Austco Healthcare Limited’s earnings last quarter?
Austco Healthcare Limited released its earnings results on Aug 27, 2026. The company reported AU$0.011 earnings per share for the quarter.
Is Austco Healthcare Limited overvalued?
According to Wall Street analysts Austco Healthcare Limited’s price is currently Undervalued.
Does Austco Healthcare Limited pay dividends?
Austco Healthcare Limited pays a Semiannually dividend of AU$0.002 which represents an annual dividend yield of 3.96%. See more information on Austco Healthcare Limited dividends here
What is Austco Healthcare Limited’s EPS estimate?
Austco Healthcare Limited’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Austco Healthcare Limited have?
Austco Healthcare Limited has 374,751,280 shares outstanding.
What happened to Austco Healthcare Limited’s price movement after its last earnings report?
Austco Healthcare Limited reported an EPS of AU$0.011 in its last earnings report. Following the earnings report the stock price went down -2.222%.
Which hedge fund is a major shareholder of Austco Healthcare Limited?
Currently, no hedge funds are holding shares in AU:AHC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Austco Healthcare Limited Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
AU$0.45 (104.55% Upside)
AU$0.45 (104.55% Upside)
Blogger Sentiment
Bullish
AU:AHC Sentiment 100%
Sector Average 63%
Sector Average 63%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-30.55%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-2.86%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Austco Healthcare Limited
Austco Healthcare Limited, through its subsidiaries, operates as a global entity focused on the development, production, and comprehensive servicing of advanced healthcare and electronic communication systems. The company's market reach extends across Australia, New Zealand, Asia, Europe, and North America. A significant product in its portfolio is Tacera, an internet protocol (IP) based nurse call solution specifically engineered for both hospitals and aged care facilities. Originally founded in 1986, the company adopted its current name, Austco Healthcare Limited, in November 2020, having previously been known as Azure Healthcare Limited. Its corporate headquarters are located in Port Melbourne, Australia.
AHC Stock 12 Month Forecast
Average Price Target
AU$0.45
▲(104.55% Upside)
Technical Analysis
Oneview Healthcare Chess Depository Interests repr 1
―
Mach7 Technologies
―
Paragon Care Limited
―
Beamtree Holdings Ltd
―
Alcidion Group Limited
―








